The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells.

The use of a somatostatin analogue (SMS 201-995) has greatly facilitated the treatment of patients with the midgut carcinoid syndrome. Clinical studies have shown that SMS reduces the peripheral levels of tumour-produced serotonin (5-HT) and tachykinins, e.g. neuropeptide K (NPK), basally and after...

Descripción completa

Detalles Bibliográficos
Autores principales: Wängberg, B., Nilsson, O., Theodorsson, E., Dahlström, A., Ahlman, H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977317/
https://www.ncbi.nlm.nih.gov/pubmed/1713051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977317/
https://www.ncbi.nlm.nih.gov/pubmed/1713051

Ejemplares similares